Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMBR | P28336 | 1/20 | 0.44 |
| ▸ | SIRT2 | Q8IXJ6 | 12/20 | 0.43 |
| ▸ | CTSS | P25774 | 3/20 | 0.40 |
| ▸ | CTSK | P43235 | 2/20 | 0.40 |
| ▸ | CTSL | P07711 | 1/20 | 0.40 |
| ▸ | CTSB | P07858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30277394 | 0.92 | NMBR (0.44) | NMBRSIRT2CTSS | |
| SCHEMBL30250367 | 0.91 | NMBR (0.42) | NMBRSIRT2CTSSCTSKCTSL | |
| SCHEMBL29427176 | 0.90 | NMBR (0.51) | NMBRSIRT2CTSSCTSKCTSL | |
| SCHEMBL29427178 | 0.90 | NMBR (0.51) | NMBRSIRT2CTSSCTSKCTSL | |
| SCHEMBL31414641 | 0.88 | NMBR (0.46) | NMBRSIRT2CTSSCTSKCTSL | |
| SCHEMBL30107533 | 0.87 | REN (0.41) | NMBRSIRT2 | |
| SCHEMBL30384691 | 0.86 | NMBR (0.40) | NMBRSIRT2 | |
| SCHEMBL29475292 | 0.84 | NMBR (0.40) | NMBRSIRT2CTSSCTSKCTSL | |
| SCHEMBL31094878 | 0.83 | SIRT2 (0.41) | NMBRSIRT2 | |
| SCHEMBL30107538 | 0.83 | SIRT2 (0.44) | NMBRSIRT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118005766-B | Solid phase synthesis method of Glepaglutide | 杭州信海医药科技有限公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-118005766-B | Solid phase synthesis method of Glepaglutide | 杭州信海医药科技有限公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-118005766-A | Solid phase synthesis method of Glepaglutide | 杭州信海医药科技有限公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-118005766-A | Solid phase synthesis method of Glepaglutide | 杭州信海医药科技有限公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-116751278-B | Preparation method of Glepaglutide | 杭州信海医药科技有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-116751278-A | Preparation method of Glepaglutide | 杭州信海医药科技有限公司 | 2023-09-15 | — | — | CN | disclosed |